Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-29T19:02:20.689Z Has data issue: false hasContentIssue false

High Mortality Among Health Personnel With COVID-19 in Mexico

Published online by Cambridge University Press:  13 October 2020

Irving Armando Domínguez-Varela*
Affiliation:
Tecnológico de Monterrey, School of Medicine and Health Sciences, Multicentric Ophthalmology Residency Program, Institute of Ophthalmology and Visual Sciences, Monterrey, México
*
Correspondence and reprint requests to Irving Armando Domínguez-Varela, Tecnológico de Monterrey, School of Medicine and Health Sciences, Institute of Ophthalmology and Visual Sciences, Monterrey, México (e-mail: irv_dominguez@hotmail.com).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© Society for Disaster Medicine and Public Health, Inc. 2020

On September 3, 2020, historical records of coronavirus disease (COVID-19) deaths among health personnel were published in Mexico with 1320 deaths, unlike the United States with only 1077.1 Approximately 1.8% in Mexico versus 0.54% in the United States of those killed by COVID-19 include health personnel (a little more than triple), representing an alert to doctors and health workers to look for the cause and with this, seek solutions.

The countries with the highest estimated numbers of health workers who have died from COVID-19 include Mexico (1320), United States (1077), UK (649), Brazil (634), Russia (631), India (573), South Africa (240), Italy (188), Peru (183), Indonesia (181), Iran (164), and Egypt (159).1

As of September 14, Mexico had one of the highest numbers of confirmed cases and deaths (668 381 and 70 821, respectively) in the region.2 Just 2 weeks ago (September 4), it was decided to enable the reopening of movie theaters, gyms, and casinos while respecting the health measures imposed by protocols. To date, some shopping malls and restaurants have been closed for not controlling the excessive number of people who have come to these places.

Comorbidities, such as diabetes and hypertension, are associated risks of poor outcomes in COVID-19 patients, with a prevalence of 18% and 32% in severe COVID-19, respectively. There’s a higher risk of intensive care unit (ICU) admission and mortality for patients with diabetes or hypertension who develop COVID-19.Reference Barrera, Shekhar and Wurth3 Obesity also represents a risk factor for ICU admission, severe COVID-19, and disease progression in patients with COVID-19.Reference Sales-Peres, de Azevedo-Silva and Bonato4 Applying these data in our country, we know that in Mexico there is a prevalence of 13.7% for diabetes, 25.5% for high blood pressure, and 31.6% for obesity.Reference Col, la Cruz-Góngora and Basto-Abreu5-7 This puts Mexico above the world prevalence with 8.7%, 26%, and 13%, respectively.8-10 The prevalence of these comorbidities could explain why Mexico is the first country in mortality of health workers due to COVID-19.

The high mortality of health personnel in Mexico can be due to many factors; among the most important could be the prevention measures and lack of personal protective equipment provided to us and the higher prevalence of comorbidities compared to that of the rest of the world. It can also be attributed to the attitude of the population to this pandemic and the correct use of protection measures.

This pandemic took everyone by surprise and has shown us how vulnerable our health system is at the national level. Nevertheless, the government has to reactivate the economy by allowing the opening of businesses; however, the health personnel (nurses, doctors, technicians, workers in the COVID-19 area) are at a greater risk of complications in this country compared with other countries.1 “It’s like we are living in two different countries, in two different Mexicos, where we doctors feel at war, but the others feel that we have already emerged from this pandemic.”

Mexicans must work together with the government and the health ministry to get ahead of this crisis and prevent each other from going separate ways in this never-ending pandemic.

Conflict of Interest Statement

The author has no conflict of interest to declare.

Acknowledgments

To all the health workers who died fighting the COVID-19 pandemic.

References

REFERENCES

México, primer lugar mundial en personal de salud fallecido por COVID-19: Amnistía Internacional. February 9, 2020. https://www.elfinanciero.com.mx/salud/mexico-primer-lugar-mundial-en-personal-de-salud-fallecido-por-covid-19-amnistia-internacional. Accessed September 7, 2020.Google Scholar
Worldometer. Coronavirus cases: statistics and charts. 2020. https://www.worldometers.info/coronavirus/coronavirus-cases/. Accessed August 18, 2020.Google Scholar
Barrera, FJ, Shekhar, S, Wurth, R, et al. Prevalence of diabetes and hypertension and their associated risks for poor outcomes in COVID-19 patients. J Endocr Soc. 2020;epub, doi: 10.1210/jendso/bvaa102.CrossRefGoogle ScholarPubMed
Sales-Peres, SH de C, de Azevedo-Silva, LJ, Bonato, RCS, et al. Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: meta-analysis of the epidemiological evidence. Obes Res Clin Pract. 2020;epub, doi: 10.1016/j.orcp.2020.07.007.CrossRefGoogle ScholarPubMed
Col, B-AA, la Cruz-Góngora, DV, Basto-Abreu, A, et al. Prevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016. Salud Publica Mex. 2020;62(1):5059. doi: 10.21149/10752.CrossRefGoogle Scholar
Campos-Nonato, I, Hernández-Barrera, L, Pedroza-Tobías, A, et al. Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016. Salud Publica Mex. 2018;60(3):233-243. doi: 10.21149/8813.CrossRefGoogle Scholar
Secretaría de Salud, Instituto Nacional de Salud Pública (INSP), Instituto Nacional de Estadística y Geografía. Encuesta Nacional de Salud y Nutrición 2018. Presentación de Resultados. https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ensanut_2018_presentacion_resultados.pdf. Accessed November 18, 2020.Google Scholar
World Health Organization. Diabetes: datos y cifras. June 8, 2020. https://www.who.int/es/news-room/fact-sheets/detail/diabetes. Accessed September 16, 2020.Google Scholar
World Health Organization. Hipertensión: datos y cifras. September 13, 2019. https://www.who.int/es/news-room/fact-sheets/detail/hypertension. Accessed September 16, 2020.Google Scholar
World Health Organization. Obesidad y sobrepeso: datos y cifras. April 1, 2020. https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight. Accessed September 16, 2020.Google Scholar